UnitedHealth Group Incorporated $UNH Position Increased by Parkman Healthcare Partners LLC

Key Points

• Parkman Healthcare Partners LLC significantly increased its stake in UnitedHealth Group by 151.1%, acquiring a total of 50,213 shares valued at approximately $26.3 million.
• Despite a quarter where UnitedHealth reported earnings of $4.08 per share, it missed analysts' expectations, revealing a net margin of 5.04% and forecasting a FY 2025 EPS of 16.000.
• The company recently declared a quarterly dividend of $2.21 per share, which will result in an annual dividend yield of 2.8% for stockholders.

Parkman Healthcare Partners LLC increased its holdings in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 151.1% during the first quarter, according to its most recent filing with the Securities & Exchange Commission. The firm owned 50,213 shares of the healthcare conglomerate's stock after acquiring an additional 30,213 shares during the period. UnitedHealth Group makes up about 3.1% of Parkman Healthcare Partners LLC's portfolio, making the stock its 8th largest holding. Parkman Healthcare Partners LLC's holdings in UnitedHealth Group were worth $26,299,000 at the end of the most recent quarter.

A number of other institutional investors have also recently modified their holdings of UNH. Bayforest Capital Ltd grew its position in shares of UnitedHealth Group by 685.7% during the 1st quarter. Bayforest Capital Ltd now owns 55 shares of the healthcare conglomerate's stock valued at $29,000 after acquiring an additional 48 shares during the period. Clal Insurance Enterprises Holdings Ltd grew its position in shares of UnitedHealth Group by 416.7% during the 1st quarter. Clal Insurance Enterprises Holdings Ltd now owns 62 shares of the healthcare conglomerate's stock valued at $32,000 after acquiring an additional 50 shares during the period. Copia Wealth Management acquired a new stake in shares of UnitedHealth Group during the 4th quarter valued at about $42,000. IAG Wealth Partners LLC purchased a new position in UnitedHealth Group in the 1st quarter valued at about $42,000. Finally, Investment Management Corp VA ADV purchased a new position in UnitedHealth Group in the 4th quarter valued at about $44,000. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Upgrades and Downgrades

A number of brokerages recently weighed in on UNH. Morgan Stanley decreased their price target on shares of UnitedHealth Group from $342.00 to $325.00 and set an "overweight" rating on the stock in a research note on Wednesday, August 20th. Wolfe Research decreased their price target on shares of UnitedHealth Group from $501.00 to $390.00 and set an "outperform" rating on the stock in a research note on Tuesday, May 20th. Sanford C. Bernstein raised their price target on shares of UnitedHealth Group from $337.00 to $379.00 and gave the company an "outperform" rating in a research note on Friday. Deutsche Bank Aktiengesellschaft decreased their target price on shares of UnitedHealth Group from $521.00 to $362.00 and set a "buy" rating on the stock in a research note on Wednesday, May 14th. Finally, Truist Financial decreased their target price on shares of UnitedHealth Group from $360.00 to $345.00 and set a "buy" rating on the stock in a research note on Wednesday, July 16th. Sixteen equities research analysts have rated the stock with a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the stock. According to data from MarketBeat.com, the company currently has a consensus rating of "Moderate Buy" and a consensus price target of $354.86.

UnitedHealth Group Trading Up 1.5%

Shares of UNH stock traded up $4.72 during trading on Friday, hitting $315.10. 14,093,579 shares of the stock traded hands, compared to its average volume of 17,228,082. The firm has a market capitalization of $285.38 billion, a P/E ratio of 13.65, a price-to-earnings-growth ratio of 2.04 and a beta of 0.44. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. The firm's fifty day moving average price is $288.78 and its 200-day moving average price is $372.56. UnitedHealth Group Incorporated has a 52-week low of $234.60 and a 52-week high of $630.73.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing the consensus estimate of $4.45 by ($0.37). The firm had revenue of $111.62 billion for the quarter, compared to analysts' expectations of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The firm's quarterly revenue was up 12.9% compared to the same quarter last year. During the same period in the previous year, the firm posted $6.80 EPS. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, research analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current fiscal year.

UnitedHealth Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th will be given a $2.21 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a yield of 2.8%. UnitedHealth Group's payout ratio is presently 38.30%.

Insider Transactions at UnitedHealth Group

In other UnitedHealth Group news, CEO Patrick Hugh Conway sold 589 shares of the business's stock in a transaction that occurred on Tuesday, June 10th. The stock was sold at an average price of $305.00, for a total value of $179,645.00. Following the sale, the chief executive officer owned 10,398 shares of the company's stock, valued at $3,171,390. The trade was a 5.36% decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. 0.28% of the stock is currently owned by insiders.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.